[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"concussion-intermediate\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:concussion-intermediate":30},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,49],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":31,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100496221","facilitating-access-to-specialty-treatment-100496221",false,"NCT05741411","Facilitating Access to Specialty Treatment","Utilizing Mobile Health to Expedite Access to Specialty Care for Youth Presenting to the Emergency Department With Concussion at Highest Risk of Developing Persisting Symptoms","Inclusion Criteria for concussed subjects:\n\n* Males and females age 13 - 18\n* Present to the Children's Hospital of Philadelphia (CHOP) Emergency Department (ED) within 72 hours of head injury\n* Meet criteria for concussion as defined by the most recent International Consensus Statement on Concussion\n* Own a smartphone\n* Meet criteria for moderate-to-high risk for Persistent Post-Concussion Symptoms according to 5P rule (score \\>3\u002F12)\n\nExclusion Criteria for concussed subjects:\n\n* Glasgow Coma Scale score \\\u003C13\n* Lower extremity trauma\n* A prior concussion within 1 month\n* Non-English speaking\n* Admission to the hospital at the initial head injury visit\n* Previously enrolled in the study\n* Inability to complete study procedures.\n\nInclusion Criteria for parents:\n\n* Child meets the study eligibility criteria\n\nExclusion Criteria for parents:\n\n* Non-English speaking\n\nInclusion Criteria for providers:\n\n* ED or specialty provider caring for at least one patient via the mobile Health (mHealth)-facilitated care handoff strategy\n\nExclusion Criteria for providers:\n\n* Non-English speaking","ALL","13 Years","18 Years",{"count":20,"type":21},210,"ESTIMATED","INTERVENTIONAL",[24],"NA","The goal of this hybrid implementation-effectiveness study is to evaluate the effectiveness (hastened recovery times) and feasibility (fidelity in connecting to concussion specialty care) of a novel mobile health intervention, designed to reduce disparities in access to specialty care through the use of remote patient monitoring (RPM) to facilitate care hand-off from the emergency department (ED) to concussion specialty care. Participants will report their symptoms and activity once daily through RPM chat technology that is linked to their electronic health record and prompts referral to specialty care.",[27,28,29,30],"Mild Traumatic Brain Injury","Concussion, Mild","Concussion, Severe","Concussion, Intermediate",[32,33,34,35],"mobile health","emergency department","persistent post-concussion symptoms","remote patient monitoring","RECRUITING","2026-05-20",{"date":39,"type":40},"2026-05-22","ACTUAL",{"date":42,"type":40},"2024-03-11",{"date":44,"type":21},"2027-08-01",{"name":46,"class":47},"Children's Hospital of Philadelphia","OTHER",1,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":4,"eligibilityCriteria":54,"healthyVolunteers":11,"sex":16,"minAge":18,"maxAge":55,"enrollmentInfo":56,"targetDuration":4,"studyType":22,"phases":58,"briefSummary":60,"conditions":61,"keywords":62,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":67,"completionDateStruct":69,"leadSponsor":71,"locationsCount":48},"100536072","phase-2-magnesium-and-riboflavin-treatment-for-post-concussion-headache-100536072","NCT06260072","Magnesium and Riboflavin Treatment for Post-Concussion Headache","Inclusion Criteria:\n\n* Seen at University of Virginia Student Health and Wellness Center or Emergency Department for Initial Visit for Concussion;\n* Less than 3 days have elapsed since their injury;\n* Able to swallow capsules\n\nExclusion Criteria:\n\n* Concussion complicated by cranial bleed, skull fracture, additional severe injury;\n* Kidney disfunction or failure;\n* Significant gastro-intestinal dysfunction;\n* Varsity Athlete;\n* Two or more previous concussions;\n* Women who are pregnant or breast feeding;\n* Taking tetracycline, fluoroquinolone, iron digoxin, chlorpromazine or penicillamine","40 Years",{"count":57,"type":21},108,[59],"PHASE2","This clinical trial will try to determine if the supplements magnesium and riboflavin will reduce the pain and duration of headaches in persons diagnosed with a concussion. The participant will be randomized to either active magnesium and riboflavin capsules or placebo (inert) capsules. The capsules will be taken once a day for 14 days. The participant will also complete a short diary form for the 14 days and will have 3 follow up visits either by telephone or in person.",[30],[63],"Concussion; Headache","2025-03-24",{"date":66,"type":40},"2025-03-27",{"date":68,"type":40},"2020-02-10",{"date":70,"type":21},"2025-12-31",{"name":72,"class":47},"University of Virginia"]